BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37743634)

  • 1. Mild cognitive impairment in patients with Parkinson´s disease and the analysis of associated factors.
    Kobak Tur E; Ari BC
    Neurol Res; 2023 Dec; 45(12):1161-1168. PubMed ID: 37743634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensities in cognitive impairment with Lewy body disease: a multicentre study.
    Gan J; Shi Z; Liu S; Li X; Liu Y; Zhu H; Shen L; Zhang G; Lu H; Gang B; Chen Z; Ji Y
    Eur J Neurol; 2023 Dec; 30(12):3711-3721. PubMed ID: 37500565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation of non-motor symptoms and sleep on balance in Parkinson's disease patients with normal cognition and mild cognitive impairment.
    Saricaoglu M; Yilmaz NH; Ozer FF; Hanoglu L
    Ir J Med Sci; 2021 Nov; 190(4):1577-1584. PubMed ID: 33449322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
    J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
    Carvalho de Abreu DC; Pieruccini-Faria F; Sarquis-Adamson Y; Black A; Fraser J; Van Ooteghem K; Cornish B; Grimes D; Jog M; Masellis M; Steeves T; Nanayakkara N; Ramirez J; Scott C; Holmes M; Ozzoude M; Berezuk C; Symons S; Mohammad Hassan Haddad S; Arnott SR; Binns M; Strother S; Beaton D; Sunderland K; Theyers A; Tan B; Zamyadi M; Levine B; Orange JB; Roberts AC; Lou W; Sujanthan S; Breen DP; Marras C; Kwan D; Adamo S; Peltsch A; Troyer AK; Black SE; McLaughlin PM; Lang AE; McIlroy W; Bartha R; ; Montero-Odasso M
    Eur J Neurol; 2023 Apr; 30(4):920-933. PubMed ID: 36692250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment.
    Chaudhary S; Kumaran SS; Kaloiya GS; Goyal V; Sagar R; Kalaivani M; Jaganathan NR; Mehta N; Srivastava A
    J Clin Neurosci; 2020 May; 75():99-105. PubMed ID: 32192853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease.
    Goldman JG; Ghode RA; Ouyang B; Bernard B; Goetz CG; Stebbins GT
    Parkinsonism Relat Disord; 2013 Sep; 19(9):806-11. PubMed ID: 23735187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of homocysteine, folate, and white matter hyperintensities in Parkinson's patients with different motor phenotypes.
    Shen Y; Dong ZF; Pan PL; Xu G; Huang JY; Liu CF
    Neurol Sci; 2019 Sep; 40(9):1855-1863. PubMed ID: 31055730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics in Parkinson's disease patients with cognitive impairment and effects of cognitive impairment on sleep].
    Gong Y; Xiong KP; Mao CJ; Huang JY; Hu WD; Han F; Chen R; Liu CF
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2637-41. PubMed ID: 24360043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive dysfuctions associated with essential tremor and Parkinson's disease].
    Chen J; Yao J; Wu Y; Chen Y; Mao C; Liu C
    Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2412-6. PubMed ID: 25400045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson's disease.
    Kwon KY; Park S; Kim RO; Lee EJ; Lee M
    Sci Rep; 2022 Jul; 12(1):11461. PubMed ID: 35794147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease.
    González-Redondo R; Toledo J; Clavero P; Lamet I; García-García D; García-Eulate R; Martínez-Lage P; Rodríguez-Oroz MC
    Eur J Neurol; 2012 Aug; 19(8):1100-7. PubMed ID: 22360775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of Balance-Gait Disorder as a Risk Factor for Cognitive Impairment, Dementia and Related Non-Motor Symptoms in Parkinson's Disease.
    Lichter DG; Benedict RHB; Hershey LA
    J Parkinsons Dis; 2018; 8(4):539-552. PubMed ID: 30124451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characterization of Parkinson's Disease Patients With Cognitive Impairment.
    Simon-Gozalbo A; Rodriguez-Blazquez C; Forjaz MJ; Martinez-Martin P
    Front Neurol; 2020; 11():731. PubMed ID: 32849203
    [No Abstract]   [Full Text] [Related]  

  • 16. Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson's disease.
    Mao CJ; Wang F; Chen JP; Yang YP; Chen J; Huang JY; Liu CF
    Clin Interv Aging; 2017; 12():1637-1644. PubMed ID: 29070942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the Chinese Version of the Montreal Cognitive Assessment-Basic for Assessing Mild Cognitive Impairment in Parkinson's Disease.
    Xu Q; Zhou M; Jiang C; Wu L; He Q; Zhao L; Dong Y; Liu J; Chen W
    Brain Sci; 2021 Nov; 11(12):. PubMed ID: 34942877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Liang K; Li X; Guo Q; Ma J; Yang H; Fan Y; Yang D; Shi X; She Z; Qi X; Gu Q; Chen S; Zheng J; Li D
    Neurobiol Dis; 2024 Jan; 190():106379. PubMed ID: 38104911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between white matter lesions and Parkinson's disease: an impact on Postural/Gait difficulty phenotype and cognitive performance.
    Sinani O; Dadouli K; Ntellas P; Kapsalaki EZ; Vlychou M; Raptis DG; Marogianni C; Markou K; Dardiotis E; Xiromerisiou G
    Neurol Res; 2022 Dec; 44(12):1122-1131. PubMed ID: 35994524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.